ClinConnect ClinConnect Logo
Search / Trial NCT05945615

Oxymetazoline Drops for Acquired Blepharoptosis From Synkinesis

Launched by MILTON S. HERSHEY MEDICAL CENTER · Jul 6, 2023

Trial Information

Current as of July 26, 2025

Enrolling by invitation

Keywords

Acquired Blepharoptosis Hyperkinesis Synkinesis Facial Paralysis Aberrant Regeneration Syndrome Post Paralysis Synkinesis Nonflaccid Facial Paralysis

ClinConnect Summary

Broadly, synkinesis is a neuromuscular condition in which voluntary muscle contraction causes simultaneous involuntary contraction of other muscle groups e.g. pursing of the lips causes involuntary closure of the eye. It is a common sequelae of facial nerve paralysis with 55% or more of patients reporting synkinetic facial movement. 2 Additionally, patients may develop hyperkinesis due to continual firing of nerves that have aberrantly regenerated, thereby causing decreased movement due to antagonistic muscle hyperactivity, tightness, spasms, and pain. These together significant affect faci...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Over 18 years of age
  • 2. Primary diagnosis of nonflaccid facial paralysis (aberrant regeneration syndrome) and acquired blepharoptosis.
  • Exclusion Criteria:
  • 1. Patients under the age of 18
  • 2. Patients on cardiac glycosides
  • 3. Patients on MAO inhibitors
  • 4. Patients with angle closure glaucoma
  • 5. Patients who experience asymmetrical eye opening due to weakness (e.g. lagophthalmos).

About Milton S. Hershey Medical Center

Milton S. Hershey Medical Center, a leading academic medical institution affiliated with Penn State University, is dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on patient-centered care, the center leverages its expertise in various medical fields to conduct rigorous clinical studies aimed at improving treatment outcomes and enhancing the understanding of complex health conditions. The facility is committed to ethical research practices and fostering collaboration among multidisciplinary teams, ensuring that participants receive the highest standard of care while contributing to the advancement of medical knowledge.

Locations

Hershey, Pennsylvania, United States

Patients applied

0 patients applied

Trial Officials

Jessyka Lighthall, MD

Principal Investigator

Penn State Health

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported